Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01104129 · ClinicalTrials.gov registry record
Stool Testing for Pancreatic Cancer
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 158
- Enrollment target
NCT01104129: Completed study, sponsored by Columbia University.
NCT01104129 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 158 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01104129 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if pancreatic cancer/pre-cancer can be detected in early stages through the molecular analysis of stool samples. Investigators hypothesize that analysis of stool samples using digital melt curve (DMC) analysis, can be used as a sensitive and specific method to detect the common genetic abnormalities present in pancreatic cancers and pre-cancerous lesions of the pancreas.
Primary Outcome
The positive mutation rates in tumor or IPMN lesions and in matched controls will be assessed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2009-07-09 |
| Est. Completion | 2016-11-29 |
What the finished NCT01104129 record still lists
NCT01104129 is an observational study that tracks outcomes without assigning an intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01104129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01104129 about?
NCT01104129 is a clinical study titled "Stool Testing for Pancreatic Cancer". The purpose of this study is to determine if pancreatic cancer/pre-cancer can be detected in early stages through the molecular analysis of stool samples. Investigators hypothesize that analysis of stool samples using digital melt curve (DMC) analysis, can be used as a sensitive and specific method ...
What is the current status of trial NCT01104129?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2009-07-09. Estimated completion is 2016-11-29.
Who is sponsoring clinical trial NCT01104129?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI